⚠️ Research Use Only. Not for human use or medical advice.
GHRH Analogue

CJC-1295 (no DAC)

Modified GRF 1-29 — 29 amino acid GHRH analogue with 4 substitutions for stability
Also known as
Mod GRF 1-29
Half-Life
~30 minutes
Storage
−20°C
Reconstitution
BAC Water
Typical Dose
100 mcg
Frequency
2–3x daily

🔬 Overview

CJC-1295 without DAC (also called Modified GRF 1-29 or Mod GRF 1-29) is a 29 amino acid analogue of endogenous growth hormone releasing hormone (GHRH). The four amino acid substitutions (at positions 2, 8, 15, and 27) improve stability against enzymatic degradation, extending the half-life from ~7 minutes (native GHRH) to approximately 30 minutes.

By mimicking GHRH, CJC-1295 (no-DAC) stimulates the pituitary to release growth hormone in a pulsatile pattern. Unlike CJC-1295 with DAC (Drug Affinity Complex), the no-DAC version produces discrete GH pulses rather than continuous elevation — preserving the natural pulsatile rhythm that appears important for GH receptor sensitivity.

CJC-1295 (no-DAC) is predominantly studied in combination with Ipamorelin, where the two peptides act synergistically — GHRH increases the pool of responsive somatotrophs while the GHRP (Ipamorelin) amplifies the pulse magnitude. The result is a substantially larger GH pulse than either peptide alone.

💉 Dosing Protocol

💡 CJC-1295 (no-DAC) should always be administered simultaneously with Ipamorelin or another GHRP for synergistic effect. Standalone use produces modest results.

ProtocolDoseFrequencyTimingNotes
Standard (solo)100 mcg2–3x dailyFastedModest effect without GHRP co-administration
Stack (+ Ipamorelin)100 mcg CJC + 200–300 mcg Ipa2–3x dailyFasted / pre-sleepMost studied protocol — synergistic GH pulse
High stack100–200 mcg CJC + 300 mcg Ipa3x dailyFasted / pre-sleep / post-workoutUpper range in research models

⚗️ Reconstitution Instructions

  1. Allow 2mg vial and BAC water to reach room temperature
  2. Add 2ml BAC water → 1000 mcg/ml concentration
  3. 100mcg dose = 0.10ml = 10 IU on insulin syringe
  4. When stacking with Ipamorelin: both can be drawn into the same syringe immediately before injection
  5. Store at 2–8°C. Use within 30 days.

🔗 Stack Guide: CJC-1295 + Ipamorelin

Ipamorelin (primary stack — inject together) BPC-157 (healing support) TB-500 (systemic recovery)

To stack CJC-1295 with Ipamorelin: reconstitute each peptide separately. At time of injection, draw the Ipamorelin dose first, then draw the CJC-1295 dose into the same syringe. The two are stable together in the syringe for immediate use. Administer as a single subcutaneous injection in a fasted state.

⚠️ Disclaimer

CJC-1295 (no DAC) is a research chemical not approved for human use. Not medical advice. Research purposes only.